◆SK Biopharm=Transfer of development and commercialization rights for the epilepsy drug Cenobamate in Japan


◆Cosmax=Patent rights related to compositions for strengthening the skin barrier, skin moisturizing, or anti-aging


◆Hanjin=Q3 operating profit of 27.6 billion KRW...7.4% increase year-on-year


Hot Picks Today

About 100 Trillion Won at Stake... "Samsung Strike Is an Unprecedented Opportunity" as Prices Surge 20% [Taiwan Chip Column] About 100 Trillion Won at Stake... "Samsung Strike Is an Unprecedented Opportunity" as Prices Surge 20% [Taiwan Chip Column]

◆KT Skylife=Acquisition of Hyundai HCN shares for 491.1 billion KRW


한글 기사 보기
This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing